{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:59Z","timestamp":1791928679084,"version":"4.3.4"},"reference-count":63,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,7,10]]},"DOI":"10.1167\/iovs.18-24133","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T17:59:13Z","timestamp":1532109553000},"page":"3405","source":"Crossref","is-referenced-by-count":7,"title":["Retinal Basal Laminar Deposits in Complement fH\/fP Mouse Model of Dense Deposit Disease"],"prefix":"10.1167","volume":"59","author":[{"given":"Delu","family":"Song","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Bhuyan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miwa","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Lesher","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodar","family":"Gullipalli","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Dunaief","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-8-3405-b01","doi-asserted-by":"crossref","unstructured":"Smith RJH, Harris CL, Pickering MC. Dense deposit disease. Mol Immunol. 2011; 48: 1604\u20131610.","DOI":"10.1016\/j.molimm.2011.04.005"},{"key":"i1552-5783-59-8-3405-b02","doi-asserted-by":"crossref","unstructured":"Servais A, Fr\u00e9meaux-Bacchi V, Lequintrec M, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2007; 44: 193\u2013199.","DOI":"10.1136\/jmg.2006.045328"},{"key":"i1552-5783-59-8-3405-b03","doi-asserted-by":"crossref","unstructured":"Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol. 1989; 73: 297\u2013302.","DOI":"10.1136\/bjo.73.4.297"},{"key":"i1552-5783-59-8-3405-b04","doi-asserted-by":"crossref","unstructured":"Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye Lond Engl. 2001; 15: 390\u2013395.","DOI":"10.1038\/eye.2001.142"},{"key":"i1552-5783-59-8-3405-b05","doi-asserted-by":"crossref","unstructured":"D'souza YB, Jones CJP, Short CD, Roberts ISD, Bonshek RE. Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II. Kidney Int. 2009; 75: 824\u2013827.","DOI":"10.1038\/ki.2008.658"},{"key":"i1552-5783-59-8-3405-b06","doi-asserted-by":"crossref","unstructured":"Colville D, Guymer R, Sinclair RA, Savige J. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II (\u201cdense deposit disease\u201d). Am J Kidney Dis. 2003; 42: E2\u2013E5.","DOI":"10.1016\/S0272-6386(03)00665-6"},{"key":"i1552-5783-59-8-3405-b07","doi-asserted-by":"crossref","unstructured":"Holz FG, Pauleikhoff D, Klein R, Bird AC. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol. 2004; 137: 504\u2013510.","DOI":"10.1016\/j.ajo.2003.11.026"},{"key":"i1552-5783-59-8-3405-b08","doi-asserted-by":"crossref","unstructured":"Duvall-Young J, Short CD, Raines MF, Gokal R, Lawler W. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol. 1989; 73: 900\u2013906.","DOI":"10.1136\/bjo.73.11.900"},{"key":"i1552-5783-59-8-3405-b09","doi-asserted-by":"crossref","unstructured":"Dunkelberger JR, Song W-C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010; 20: 34\u201350.","DOI":"10.1038\/cr.2009.139"},{"key":"i1552-5783-59-8-3405-b10","doi-asserted-by":"crossref","unstructured":"Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease. J Immunol. 2006; 176: 1305\u20131310.","DOI":"10.4049\/jimmunol.176.3.1305"},{"key":"i1552-5783-59-8-3405-b11","doi-asserted-by":"crossref","unstructured":"Holers VM. The spectrum of complement alternative pathway-mediated diseases. Immunol Rev. 2008; 223: 300\u2013316.","DOI":"10.1111\/j.1600-065X.2008.00641.x"},{"key":"i1552-5783-59-8-3405-b12","doi-asserted-by":"crossref","unstructured":"Song W-C. Complement regulatory proteins and autoimmunity. Autoimmunity. 2006; 39: 403\u2013410.","DOI":"10.1080\/08916930600739647"},{"key":"i1552-5783-59-8-3405-b13","doi-asserted-by":"crossref","unstructured":"J\u00f3zsi M, Zipfel PF. Factor H family proteins and human diseases. Trends Immunol. 2008; 29: 380\u2013387.","DOI":"10.1016\/j.it.2008.04.008"},{"key":"i1552-5783-59-8-3405-b14","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez de C\u00f3rdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, S\u00e1nchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol. 2004; 41: 355\u2013367.","DOI":"10.1016\/j.molimm.2004.02.005"},{"key":"i1552-5783-59-8-3405-b15","doi-asserted-by":"crossref","unstructured":"Atkinson JP, Goodship THJ. Complement factor H and the hemolytic uremic syndrome. J Exp Med. 2007; 204: 1245\u20131248.","DOI":"10.1084\/jem.20070664"},{"key":"i1552-5783-59-8-3405-b16","doi-asserted-by":"crossref","unstructured":"Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005; 308: 421\u2013424.","DOI":"10.1126\/science.1110189"},{"key":"i1552-5783-59-8-3405-b17","doi-asserted-by":"crossref","unstructured":"Giannakis E, Jokiranta TS, Male DA, et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol. 2003; 33: 962\u2013969.","DOI":"10.1002\/eji.200323541"},{"key":"i1552-5783-59-8-3405-b18","doi-asserted-by":"crossref","unstructured":"Levy M, Halbwachs-Mecarelli L, Gubler MC, et al. H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int. 1986; 30: 949\u2013956.","DOI":"10.1038\/ki.1986.278"},{"key":"i1552-5783-59-8-3405-b19","doi-asserted-by":"crossref","unstructured":"Fearon DT, Austen KF. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med. 1975; 142: 856\u2013863.","DOI":"10.1084\/jem.142.4.856"},{"key":"i1552-5783-59-8-3405-b20","doi-asserted-by":"crossref","unstructured":"Blatt AZ, Pathan S, Ferreira VP. Properdin: a tightly regulated critical inflammatory modulator. Immunol Rev. 2016; 274: 172\u2013190.","DOI":"10.1111\/imr.12466"},{"key":"i1552-5783-59-8-3405-b21","doi-asserted-by":"crossref","unstructured":"Kimura Y, Zhou L, Miwa T, Song W-C. Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury. J Clin Invest. 2010; 120: 3545\u20133554.","DOI":"10.1172\/JCI41782"},{"key":"i1552-5783-59-8-3405-b22","doi-asserted-by":"crossref","unstructured":"Dimitrova P, Ivanovska N, Schwaeble W, Gyurkovska V, Stover C. The role of properdin in murine zymosan-induced arthritis. Mol Immunol. 2010; 47: 1458\u20131466.","DOI":"10.1016\/j.molimm.2010.02.007"},{"key":"i1552-5783-59-8-3405-b23","doi-asserted-by":"crossref","unstructured":"Miwa T, Sato S, Gullipalli D, Nangaku M, Song W-C. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice. J Immunol. 2013; 190: 3552\u20133559.","DOI":"10.4049\/jimmunol.1202275"},{"key":"i1552-5783-59-8-3405-b24","doi-asserted-by":"crossref","unstructured":"Hourcade DE, Akk AM, Mitchell LM, Zhou H, Hauhart R, Pham CTN. Anti-complement activity of the Ixodes scapularis salivary protein Salp20. Mol Immunol. 2016; 69: 62\u201369.","DOI":"10.1016\/j.molimm.2015.11.008"},{"key":"i1552-5783-59-8-3405-b25","doi-asserted-by":"crossref","unstructured":"Zhou H-F, Yan H, Stover CM, et al. Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysm. Proc Natl Acad Sci U S A. 2012; 109: E415\u2013E422.","DOI":"10.1073\/pnas.1119000109"},{"key":"i1552-5783-59-8-3405-b26","doi-asserted-by":"crossref","unstructured":"Wang Y, Miwa T, Ducka-Kokalari B, et al. Properdin contributes to allergic airway inflammation through local C3a generation. J Immunol. 2015; 195: 1171\u20131181.","DOI":"10.4049\/jimmunol.1401819"},{"key":"i1552-5783-59-8-3405-b27","doi-asserted-by":"crossref","unstructured":"Stover CM, Luckett JC, Echtenacher B, et al. Properdin plays a protective role in polymicrobial septic peritonitis. J Immunol. 2008; 180: 3313\u20133318.","DOI":"10.4049\/jimmunol.180.5.3313"},{"key":"i1552-5783-59-8-3405-b28","doi-asserted-by":"crossref","unstructured":"Ivanovska ND, Dimitrova PA, Luckett JC, El-Rachkidy Lonnen R, Schwaeble WJ, Stover CM. Properdin deficiency in murine models of nonseptic shock. J Immunol. 2008; 180: 6962\u20136969.","DOI":"10.4049\/jimmunol.180.10.6962"},{"key":"i1552-5783-59-8-3405-b29","doi-asserted-by":"crossref","unstructured":"Ruseva MM, Vernon KA, Lesher AM, et al. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency. J Am Soc Nephrol JASN. 2013; 24: 43\u201352.","DOI":"10.1681\/ASN.2012060571"},{"key":"i1552-5783-59-8-3405-b30","doi-asserted-by":"crossref","unstructured":"Lesher AM, Zhou L, Kimura Y, et al. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. J Am Soc Nephrol JASN. 2013; 24: 53\u201365.","DOI":"10.1681\/ASN.2012060570"},{"key":"i1552-5783-59-8-3405-b31","doi-asserted-by":"crossref","unstructured":"Song D, Song Y, Hadziahmetovic M, Zhong Y, Dunaief JL. Systemic administration of the iron chelator deferiprone protects against light\u2013induced photoreceptor degeneration in the mouse retina. Free Radic Biol Med. 2012; 53: 64\u201371.","DOI":"10.1016\/j.freeradbiomed.2012.04.020"},{"key":"i1552-5783-59-8-3405-b32","doi-asserted-by":"crossref","unstructured":"Cousins SW, Marin-Casta\u00f1o ME, Espinosa-Heidmann DG, Alexandridou A, Striker L, Elliot S. Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice. Invest Ophthalmol Vis Sci. 2003; 44: 1221\u20131229.","DOI":"10.1167\/iovs.02-0285"},{"key":"i1552-5783-59-8-3405-b33","doi-asserted-by":"crossref","unstructured":"Song D, Song J, Wang C, Li Y, Dunaief JL. Berberine protects against light-induced photoreceptor degeneration in the mouse retina. Exp Eye Res. 2016; 145: 1\u20139.","DOI":"10.1016\/j.exer.2015.10.005"},{"key":"i1552-5783-59-8-3405-b34","doi-asserted-by":"crossref","unstructured":"Cinader B, Dubiski S, Wardlaw AC. Distribution, inheritance, and properties of an antigen, MUB1, and its relation to hemolytic complement. J Exp Med. 1964; 120: 897\u2013924.","DOI":"10.1084\/jem.120.5.897"},{"key":"i1552-5783-59-8-3405-b35","doi-asserted-by":"crossref","unstructured":"Churchill WH, Weintraub RM, Borsos T, Rapp HJ. Mouse complement: the effect of sex hormones and castration on two of the late-acting components. J Exp Med. 1967; 125: 657\u2013672.","DOI":"10.1084\/jem.125.4.657"},{"key":"i1552-5783-59-8-3405-b36","doi-asserted-by":"crossref","unstructured":"Williams AL, Gullipalli D, Ueda Y, et al. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy. Kidney Int. 2017; 91: 1386\u20131397.","DOI":"10.1016\/j.kint.2016.11.018"},{"key":"i1552-5783-59-8-3405-b37","doi-asserted-by":"crossref","unstructured":"Liu J, Miwa T, Hilliard B, et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med. 2005; 201: 567\u2013577.","DOI":"10.1084\/jem.20040863"},{"key":"i1552-5783-59-8-3405-b38","doi-asserted-by":"crossref","unstructured":"Michielsen B, Leys A, Van Damme B, Missotten L. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Doc Ophthalmol. 1990; 76: 219\u2013229.","DOI":"10.1007\/BF00142681"},{"key":"i1552-5783-59-8-3405-b39","doi-asserted-by":"crossref","unstructured":"Kim RY, Faktorovich EG, Kuo CY, Olson JL. Retinal function abnormalities in membranoproliferative glomerulonephritis type II. Am J Ophthalmol. 1997; 123: 619\u2013628.","DOI":"10.1016\/S0002-9394(14)71074-8"},{"key":"i1552-5783-59-8-3405-b40","doi-asserted-by":"crossref","unstructured":"Leys A, Vanrenterghem Y, Van Damme B, Snyers B, Pirson Y, Leys M. Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol. 1991; 229: 406\u2013410.","DOI":"10.1007\/BF00166300"},{"key":"i1552-5783-59-8-3405-b41","doi-asserted-by":"crossref","unstructured":"Davis TM, Holdright DR, Schulenberg WE, Turner RC, Joplin GF. Retinal pigment epithelial change and partial lipodystrophy. Postgrad Med J. 1988; 64: 871\u2013874.","DOI":"10.1136\/pgmj.64.757.871"},{"key":"i1552-5783-59-8-3405-b42","doi-asserted-by":"crossref","unstructured":"Leys A, Michielsen B, Leys M, Vanrenterghem Y, Missotten L, Van Damme B. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefes Arch Clin Exp Ophthalmol. 1990; 228: 499\u2013504.","DOI":"10.1007\/BF00918479"},{"key":"i1552-5783-59-8-3405-b43","doi-asserted-by":"crossref","unstructured":"Ulbig MR, Riordan-Eva P, Holz FG, Rees HC, Hamilton PA. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am J Ophthalmol. 1993; 116: 410\u2013413.","DOI":"10.1016\/S0002-9394(14)71397-2"},{"key":"i1552-5783-59-8-3405-b44","doi-asserted-by":"crossref","unstructured":"Curcio CA, Presley JB, Malek G, Medeiros NE, Avery DV, Kruth HS. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp Eye Res. 2005; 81: 731\u2013741.","DOI":"10.1016\/j.exer.2005.04.012"},{"key":"i1552-5783-59-8-3405-b45","doi-asserted-by":"crossref","unstructured":"Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007; 48: 968\u2013977.","DOI":"10.1167\/iovs.06-0443"},{"key":"i1552-5783-59-8-3405-b46","doi-asserted-by":"crossref","unstructured":"Lommatzsch A, Hermans P, M\u00fcller KD, Bornfeld N, Bird AC, Pauleikhoff D. Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch Clin Exp Ophthalmol. 2008; 246: 803\u2013810.","DOI":"10.1007\/s00417-007-0749-4"},{"key":"i1552-5783-59-8-3405-b47","doi-asserted-by":"crossref","unstructured":"Miller JW. Age-related macular degeneration revisited \u2013 piecing the puzzle: the LXIX Edward Jackson Memorial Lecture. Am J Ophthalmol. 2013; 155: 1\u201335.e13.","DOI":"10.1016\/j.ajo.2012.10.018"},{"key":"i1552-5783-59-8-3405-b48","doi-asserted-by":"crossref","unstructured":"Sarks SH. Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol. 1976; 60: 324\u2013341.","DOI":"10.1136\/bjo.60.5.324"},{"key":"i1552-5783-59-8-3405-b49","unstructured":"Curcio CA, Johnson M. Structure, function, and pathology of Bruch's membrane. Elastic. 2013; 14652: 210\u2013213."},{"key":"i1552-5783-59-8-3405-b50","unstructured":"Luo C, Chen M, Xu H. Complement gene expression and regulation in mouse retina and retinal pigment epithelium\/choroid. Mol Vis. 2011; 17: 1588\u20131597."},{"key":"i1552-5783-59-8-3405-b51","doi-asserted-by":"crossref","unstructured":"Luo C, Zhao J, Madden A, Chen M, Xu H. Complement expression in retinal pigment epithelial cells is modulated by activated macrophages. Exp Eye Res. 2013; 112: 93\u2013101.","DOI":"10.1016\/j.exer.2013.04.016"},{"key":"i1552-5783-59-8-3405-b52","doi-asserted-by":"crossref","unstructured":"Natoli R, Fernando N, Jiao H, et al. Retinal macrophages synthesize C3 and activate complement in AMD and in models of focal retinal degeneration. Invest Ophthalmol Vis Sci. 2017; 58: 2977\u20132990.","DOI":"10.1167\/iovs.17-21672"},{"key":"i1552-5783-59-8-3405-b53","doi-asserted-by":"crossref","unstructured":"Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol. 1999; 117: 329\u2013339.","DOI":"10.1001\/archopht.117.3.329"},{"key":"i1552-5783-59-8-3405-b54","doi-asserted-by":"crossref","unstructured":"Marmorstein LY, McLaughlin PJ, Peachey NS, Sasaki T, Marmorstein AD. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum Mol Genet. 2007; 16: 2423\u20132432.","DOI":"10.1093\/hmg\/ddm199"},{"key":"i1552-5783-59-8-3405-b55","doi-asserted-by":"crossref","unstructured":"Espinosa-Heidmann DG, Suner IJ, Catanuto P, Hernandez EP, Marin-Castano ME, Cousins SW. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci. 2006; 47: 729\u2013737.","DOI":"10.1167\/iovs.05-0719"},{"key":"i1552-5783-59-8-3405-b56","doi-asserted-by":"crossref","unstructured":"Dithmar S, Sharara NA, Curcio CA, et al. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol. 2001; 119: 1643\u20131649.","DOI":"10.1001\/archopht.119.11.1643"},{"key":"i1552-5783-59-8-3405-b57","doi-asserted-by":"crossref","unstructured":"Weber BH, Vogt G, Pruett RC, St\u00f6hr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet. 1994; 8: 352\u2013356.","DOI":"10.1038\/ng1294-352"},{"key":"i1552-5783-59-8-3405-b58","doi-asserted-by":"crossref","unstructured":"Hayward C, Shu X, Cideciyan AV, et al. Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Hum Mol Genet. 2003; 12: 2657\u20132667.","DOI":"10.1093\/hmg\/ddg289"},{"key":"i1552-5783-59-8-3405-b59","doi-asserted-by":"crossref","unstructured":"Stanton JB, Marmorstein AD, Zhang Y, Marmorstein LY. Deletion of Efemp1 is protective against the development of sub-RPE deposits in mouse eyes, deletion of Efemp1 is protective against BLamD. Invest Ophthalmol Vis Sci. 2017; 58: 1455\u20131461.","DOI":"10.1167\/iovs.16-20955"},{"key":"i1552-5783-59-8-3405-b60","doi-asserted-by":"crossref","unstructured":"Toomey CB, Kelly U, Saban DR, Bowes Rickman C. Regulation of age-related macular degeneration-like pathology by complement factor H. Proc Natl Acad Sci U S A. 2015; 112: E3040\u2013E3049.","DOI":"10.1073\/pnas.1424391112"},{"key":"i1552-5783-59-8-3405-b61","doi-asserted-by":"crossref","unstructured":"Ding J-D, Kelly U, Landowski M, et al. Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice. Am J Pathol. 2015; 185: 29\u201342.","DOI":"10.1016\/j.ajpath.2014.08.026"},{"key":"i1552-5783-59-8-3405-b62","doi-asserted-by":"crossref","unstructured":"Lesher AM, Nilsson B, Song W-C. Properdin in complement activation and tissue injury. Mol Immunol. 2013; 56: 191\u2013198.","DOI":"10.1016\/j.molimm.2013.06.002"},{"key":"i1552-5783-59-8-3405-b63","doi-asserted-by":"crossref","unstructured":"Toomey CB, Landowski M, Klingeborn M, et al. Effect of Anti-C5a therapy in a murine model of early\/intermediate dry age-related macular degeneration. Invest Ophthalmol Vis Sci. 2018; 59: 662\u2013673.","DOI":"10.1167\/iovs.17-23134"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2688004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:55Z","timestamp":1791927055000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24133","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,10]]}}}